Clin2
NCT05672615Possibly a fitRecruiting

Mood changes during bladder cancer treatment with BCG

Non-Muscle Invasive Bladder Cancer

Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.

This study looks at how bladder cancer treatment with BCG may affect mood and emotional well-being. It may help doctors understand which patients experience mood changes during care.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
42 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You have bladder cancer that is non-muscle invasive and confirmed by biopsy/pathology
  • You are 18 years old or older
  • You can understand the study and sign written informed consent
  • Your cancer type allows treatment directly into the bladder with BCG
  • You are not pregnant

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05327647Recruiting· Phase 2
Bicalutamide with BCG for bladder cancer after BCG treatment

This trial studies whether bicalutamide can improve outcomes for people with non-muscle-invasive bladder cancer who are starting BCG through the bladder. It may help prevent cancer from coming back or progressing after BCG.

London, Ontario
NCT06241755Recruiting· Phase 3
BCG to prevent bladder cancer return after surgery

This study tests if BCG therapy can prevent bladder cancer from coming back after surgery. It's for people with early-stage bladder cancer that hasn't spread into the muscle layer.

Guangzhou, Guangdong
NCT06972615Recruiting· Phase 2
Bladder chemo plus pembrolizumab for BCG-treated cancer

This trial tests a combination of chemotherapy placed directly into the bladder and an immunotherapy drug called pembrolizumab (given through a vein) for people with high-risk bladder cancer that has not completely responded to or has returned after BCG treatment.

CABA
NCT06245603Recruiting
Testing Hydeal Cyst with standard treatment for bladder cancer

This study tests a bladder instillation called Hydeal Cyst, given alongside standard BCG or MMC therapy, to see if it helps reduce side effects or improve outcomes for people with non-muscle invasive bladder cancer.

Bergamo
NCT07048496Recruiting
At-home BCG treatment for bladder cancer with support

This study is testing a way for people with early-stage bladder cancer to receive their BCG treatment at home, with extra support. It aims to see if doing treatment at home is safe and helpful for patients.

Philadelphia, Pennsylvania
NCT07474519Recruiting· Phase 4
Studying position and dwell time for BCG bladder cancer treatment

This trial tests whether changing your position while receiving BCG treatment (a liquid medicine placed directly into the bladder) can help it work better. You will wear a fitness tracker for a few days to monitor activity.

Columbus, Ohio

Hear when a new Non Muscle Invasive Bladder Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.